SEARCH

SEARCH BY CITATION

The majority of events during The Liver Meeting® will take place in the Walter E. Washington Convention Center.

Those events not taking place at the convention center will be noted. Sessions marked with an asterisk *require a ticket for entrance.

Day/Time Activity Location Page
Friday, November 1
7: 55 am - 3: 00 pmAASLD/ASGE Endoscopy Course*Room 146A36A
8: 00 am - 12: 30 pmAASLD/IASL Program*Room 14537A
8: 00 am - 3: 30 pmAASLD/ILTS Transplant Course*Room 146BC38A
Noon - 3: 00 pmAASLD/NASPGHAN Pediatric Symposium*Room 150A39A
Noon - 3: 30 pmCareer Development Workshop*Room 152A40A
12: 30 - 3: 00 pmCompetency Training WorkshopRoom 152B41A
3: 30 - 7: 30 pmPostgraduate Course*Hall E/General Session42A
Saturday, November 2
8: 00 am - 5: 00 pmPostgraduate Course*Hall E/General Session42A
9: 00 am - NoonLiver Transplantation and Surgery SIG Program:Room 146A44A
Surviving and Thriving - A Value Based Approach for Multidisciplinary Liver Programs
12: 15 - 1: 15 pmMeet-the-Professor Luncheons*Check your Ticket45A
2: 00 - 7: 30 pmPoster Session IHall E
• Access to Care 92A
•Acute Liver Failure 92A
• Behavioral and Practice Issues 94A
• Cellular Immunobiology 95A
• Drug Metabolism and Toxicity 96A
• Economics of Care 97A
• Experimental Cholestasis 98A
• Gene Expression and Therapy 98A
• Genetic Liver Disease 100A
• HBV Immunopathogenesis 100A
• HCV Therapy: The Developmental Pipeline 102A
• Mechanisms of Injury 104A
• Non-parenchymal Cell Biology 105A
• Signal Transduction and Cell Function 106A
• Steatohepatitis Clinical Themes 107A
• Steatohepatitis Mechanisms 113A
3: 30 - 7: 00 pmTransplant Surgery Workshop*Room 146A46A
5: 15 - 6: 15 pmAASLD Business Meeting (Members Only)Hall E/General Session46A
5: 00 - 7: 30 pmExhibits OpenHall D45A
5: 00 - 7: 30 pmOpening ReceptionHall D45A
Sunday, November 3
6: 45 - 7: 45 amEarly Morning Workshops*Check your ticket47A
8: 00 - 9: 30 amTransplant Plenary IHall E/General Session48A
8: 00 am - NoonBasic Research Workshop*Room 14549A
8: 00 am - 1: 30 pmHepatology Associates Course*Room 14750A
8: 00 am - 5: 30 pmPoster Session IIHall E
•Autoimmune Liver Disease 119A
• Basic Fibrosis Research 120A
•Clinical and Translational Studies in Fibrosis 122A
• HBV Epidemiology and Prevention 124A
• HBV Natural History and Outcomes 126A
• HBV Trials and Treatments 128A
• HBV Virology and Diagnostics 135A
• HCV Therapeutics: New Agents 138A
• Liver Transplant Donors and Allocation 141A
• Living Donors and Split Livers 143A
• PBC and PSC 144A
• Pediatric Liver Disease 145A

Meeting-at-a-Glance (continued)

Day/TimeActivityLocationPage
Sunday, November 3
9:30 am – 3:00 pmExhibits OpenHall D48A
9:30 – 10:00 amThomas E. Starzl Transplant Surgery State-of-the-Art LectureHall E/General Session51A
10:00 – 10:30 amCoffee BreakHall D51A
10:30 am – NoonTransplant Plenary IIHall E/General Session52A
Noon – 12:30 pmHans Popper Basic Science State-of-the-Art LectureHall E/General Session53A
1:00 – 5:00 pmFederal FocusRoom 15154A
1:30 – 2:00 pmSnack BreakHall D55A
2:00 – 2:30 pmPresident's ChoiceHall E/General Session55A
2:45 – 3:00 pmDistinguished Clinician Educator/Mentor Award PresentationHall E/General Session56A
3:00 – 4:30 pmGeneral Hepatology UpdateBallroom AB56A
3:00 – 4:30 pmParallel Sessions
1. Biliary Atresia and Neonatal CholestasisRoom 146A57A
2. Epidemiology of Viral HepatitisRoom 14757A
3. Fibrosis: Basic Mechanisms and Novel TherapeuticsRoom 150A58A
4. HBV TreatmentRoom 14558A
5. HCV Therapeutics: Real World ExperiencesHall E/General Session59A
6. Living Donors Transplantation and Hepatic ResectionRoom 152A59A
7. Pathological Mechanisms in NAFLDBallroom C60A
8. Stem Cells and ProgenitorsRoom 152B60A
9. Viral Hepatitis and Liver TransplantationRoom 146BC61A
4:00 – 6:00 pmABIM Maintenance of Certification*Room 150B61A
4:45 – 6:15 pmParallel Sessions
10. From Genes to FunctionRoom 152B62A
11. HCV Therapeutics: New AgentsHall E/General Session62A
12. NASH: Diagnosis and TreatmentBallroom C63A
13. PBC, PSC and Autoimmune DiseaseRoom 146BC63A
14. Predictors of Liver Transplantation OutcomesRoom 152A64A
15. Translational and Experimental Research in Pediatric HepatologyRoom 146A64A
4:45 – 6:45 pmHepatitis B SIG Program: Challenges in Diagnosis and Management of Chronic Hepatitis B Virus Infection in Endemic CountriesRoom 14565A
4:45 – 6:45 pmAcute on Chronic Liver Failure SIG Program: The Changing Spectrum of Bacterial Infections in CirrhosisRoom 14765A
4:45 – 6:45 pmLiver Cell Biology in Hepatic Diseases and Liver Fibrosis SIG Program: The Cell Biology of Hepatic DiseaseRoom 150A66A
Monday, November 4
6:45 – 7:45 amEarly Morning Workshops*Check your ticket67A
8:00 – 9:30 amPresidential Plenary: Scientific Advances in HepatologyHall E/General Session68A
8:00 am – 5:30 pmPoster Session IIIHall E
•Adaptive Immunity 149A
•Alcohol and the Liver 149A
• Bile Acids, Cholesterol, and Cholangiocyte Biology 151A
• Complications of Cirrhosis 152A
•HCV: Diagnosis and Natural History 158A
•HCV: Virology 161A
•Hepatotoxicity: Apoptosis and Necrosis 163A
•Hepatotoxicity: Oxidative Stress 164A
• Imaging of the Liver 164A
• Innate Immunity 166A
• Portal Hypertension: Experimental 167A
• Portal Hypertension: Varices and Bleeding 169A
• Stem Cell Biology 170A
• Transplant Outcomes and Immunosuppression 171A
• Viral Hepatitis and Transplant 175A
9:30 – 10:00 amDistinguished Service and Distinguised Achievement Award PresentationsHall E/General Session68A
9:30 am – 3:00 pmExhibits OpenHall D67A
10:00 – 10:30 amHyman J. Zimmerman Hepatotoxicity State-of-the-Art LectureHall E/General Session69A
10:30 – 11:00 amCoffee BreakHall D69A

Meeting-at-a-Glance (continued)

Day/TimeActivityLocationPage
  1. a

    Indicates a ticket is required for entrance.

Monday, November 4
11:00 am – 12:30 pmAdvances for PractitionersBallroom AB70A
11:00 am – 12:30 pmPresidential Plenary: Translational Advances in HepatologyHall E/General Session71A
11:45 am – 1:15 pmProfessional Development Workshop*Renaissance Hotel,72A
Congressional Hall B
12:30 – 1:30 pmACP Lecture152A72A
1:30 – 2:00 pmSnack BreakHall D72A
2:00 – 4:00 pmGlobal ForumRoom 15173A
3:00 – 4:30 pmEmerging Trends SymposiumRoom 14773A
2:45 – 4:30 pmLate-breaking Abstract SessionHall E/General Session73A
3:00 – 4:30 pmParallel Sessions
16. Cholangiocyte BiologyRoom 150B74A
17. Clinical Advances in Pediatric HepatologyRoom 146A74A
18. Complications of CirrhosisBallroom AB75A
19. HBV Basic VirologyRoom 14575A
20. HCV Diagnosis and Natural HistoryBallroom C76A
21. Inflammation and FibrosisRoom 150A76A
22. Signaling in HepatotoxicityRoom 152A77A
4:45 – 6:15 pmHCV SymposiumHall E/General Session78A
4:45 – 6:15 pmParallel Sessions
23. Cholesterol and Bile Acid MetabolismRoom 150B79A
24. Diagnosis of Liver TumorsRoom 14779A
25. Diagnosis, Prognosis, and Treatment of VaricesBallroom AB80A
26. Experimental Portal HypertensionRoom 150A80A
27. Genetic Liver DiseaseRoom 152B81A
28. HBV Natural History and Long-term OutcomesRoom 14581A
29. HCV VirologyRoom 15182A
30. Innate Immunity in Hepatitis C Infection and FibrosisRoom 146BC82A
31. Macrophages and Immunity in Alcoholic Liver Disease and RegenerationRoom 146A83A
4:45 – 6:45 pmHepatotoxicity SIG Program: Cell Death in HepatotoxicityRoom 152A84A
Pediatric Liver Disorders and Steatosis and Steatohepatitis SIG Program: Selected Controversies in Adult and Pediatric NAFLD and NASHBallroom C84A
Tuesday, November 5
6:45 – 7:45 amEarly Morning Workshops*Check your ticket85A
8:00 – 9:30 amPresidential Plenary: Viral HepatitisHall E/General Session86A
8:00 am – NoonPoster Session IVHall E
• Cholestasis 177A
• Experimental Hepatocarcinogenesis 177A
•HCV Therapeutics: Approved Agents 181A
•HCV: Pathogenesis 190A
•Health Care Delivery 193A
• Liver Cancer 195A
• Viral Hepatitis: Epidemiology and Diagnosis 203A
9:30 – 9:45 amHoward Koh PresentationHall E/General Session87A
9:30 – 10:30 amHepatitis DebriefHall E/General Session87A
10:30 – 11:00 amLeon Schiff State-of-the-Art LectureHall E/General Session87A
11:15 am – 12:45 pmParallel Sessions
32. Alcohol Induced Mechanisms of Injury and Therapeutic TargetsRoom 14588A
33. Experimental CholestasisRoom 152A88A
34. Experimental HepatocarcinogenesisRoom 146A89A
35. HCV: PathogenesisBallroom C89A
36. Health Care Quality and Cost EffectivenessRoom 150B90A
37. Liver Cancer: Pathogenesis and TreatmentBallroom AB90A
38. Signal Transduction and Nuclear ReceptorsRoom 152B91A
39. Sterile Inflammation and ImmunobiologyRoom 150A91A

General Information

  1. Top of page
  2. General Information
  3. Abstract Embargo
  4. ADA Compliance
  5. Limited License for Use

Abstracts

Access to the abstracts and text at the meeting is available in many formats:

  • Online Itinerary Planner*
  • Meeting App
  • USB drive distributed at registration*
  • ePosters*
  • LiverLearning®

Bring your October supplement to HEPATOLOGY to the meeting (members and subscribers).

*The Abstracts on USB Flash-drive is supported by AbbVie

*The online Itinerary Planner is supported by Bristol-Myers Squibb

*ePosters are supported by Merck

Notice: In order to minimize waste, additional copies of the supplement will not be available at the meeting.

Abstract Embargo

  1. Top of page
  2. General Information
  3. Abstract Embargo
  4. ADA Compliance
  5. Limited License for Use

Accepted abstracts are made available to the public on the AASLD website and are published in the October supplement to HEPATOLOGY. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website. Academic institutions, private organizations, and companies with products whose values may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract on the AASLD website. However, information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting is embargoed from release to the general public until the first day of The Liver Meeting®.

Information released prior to this day is a violation of the AASLD Abstract Embargo Policy and the abstract is subject to withdrawal from The Liver Meeting® program. Authors are responsible for notifying financial and other sponsors about this policy.

AASLD may allow for exceptions, on a case-by-case basis, to the Abstract Embargo Policy for compelled disclosures mandated by federal securities laws. However, AASLD requires the company President, General Counsel, or other appropriate official of a company seeking such an exception to attest in writing to the specific facts in support of the request, including exactly how the securities laws are implicated, with statutory citation(s). General statements of the need to comply with the law will not be considered sufficient. Requests for an exception must be sent to the AASLD Executive Director (scathcart@aasld.org). AASLD requires a minimum of five (5) days from receipt of the request to evaluate the request. In granting an exception, the AASLD requires the company to state in their public disclosure that the complete and final results will be presented at The Liver Meeting®. The AASLD will also require the inclusion of unreleased and unique data in such a presentation at The Liver Meeting®.

Public release of a journal article relevant to the abstract will be considered an exception to the Embargo Policy if at the time of the abstract submission deadline, the decision concerning the manuscript had not been revealed to the authors.

ADA Compliance

  1. Top of page
  2. General Information
  3. Abstract Embargo
  4. ADA Compliance
  5. Limited License for Use

The Walter E. Washington Convention Center and all participating hotels in The Liver Meeting® are fully accessible to the physically challenged. Anyone who has a need for special assistance should notify the appropriate hotel, the Convention Center or AASLD and indicate the type of assistance needed. AASLD cannot ensure the availability of appropriate assistance without prior notice.

Exhibit Hall • Hall D

The Exhibit Hall, an informative and important component of The Liver Meeting®, provides you with a valuable opportunity to meet with representatives from various organizations that are committed to the field of hepatology. A complete listing of exhibitors and their product descriptions can be found on our website at www.thelivermeeting.org/exhibitors

Exhibit Hours

Saturday, November 2 5:00 – 7:30 pm

Sunday, November 3 9:30 am – 3:00 pm

Monday, November 4 9:30 am – 3:00 pm

Posters • Hall E

The Poster Sessions are an important event during The Liver Meeting®. Approximately 520 posters will be displayed daily. The top 10% of posters accepted are designated in the program as a “Presidential Poster of Distinction”.

Posters should be set-up and viewed during the following times:

Poster Session I

Saturday, November 2

Set-up: 8:00 am – 2:00 pm

Viewing Time: 2:00 – 7:30 pm

Presentation Time: 5:30 – 7:00 pm*

*Authors are available during this time

Dismantle Time: 7:30 – 8:00 pm

*Posters must be displayed until 7:30 pm

Poster Session II

Sunday, November 3

Set-up: 6:30 – 8:00 am

Viewing Time: 8:00 am – 5:30 pm

Presentation Time: 12:30 – 2:00 pm*

*Authors are available during this time

Dismantle Time: 5:30 – 6:00 pm

*Posters must be displayed until 5:30 pm

Poster Session III

Monday, November 4

Set-up: 6:30 – 8:00 am

Viewing Time: 8:00 am – 5:30 pm

Presentation Time: 12:30 – 2:00 pm*

*Authors are available during this time

Dismantle Time: 5:30 – 6:00 pm

*Posters must be displayed until 5:30 pm

Poster Session IV

Tuesday, November 5

Set-up: 6:30 – 8:00 am

Viewing Time: 8:00 am – Noon

Presentation Time: 10:30 am – Noon*

*Authors are available during this time

Dismantle Time: Noon – 12:30 pm

*Posters must be displayed until Noon

Posters must be dismantled immediately following the viewing time. Posters left on the boards will be removed and discarded.

Note: No CME will be provided for Poster Sessions.

ePosters • Outside Hall E

ePosters are an interactive advanced viewing system that brings posters to virtual life for The Liver Meeting® attendees. ePosters will be available to view on the first day of the meeting. ePosters will be available post-meeting on LiverLearning®.

ePosters are supported by Merck.

Press Room • Room 103A

Friday, November 1 1:00 – 5:00 pm

Saturday, November 2 8:00 am – 6:00 pm

Sunday, November 3 8:00 am – 5:00 pm

Monday, November 4 8:00 am – 5:00 pm

Tuesday, November 5 8:00 am – Noon

The official press contact for The Liver Meeting® is:

Ann Haran

AASLD

1001 N. Fairfax Street, Suite 400

Alexandria, VA 22314-2720

Telephone: 703-299-9766

Fax: 703-299-9676

Registration Hours • West Salon

Thursday, October 31 2:00 – 8:00 pm

Friday, November 1 6:30 am – 7:30 pm

Saturday, November 2 6:30 am – 7:30 pm

Sunday, November 3 6:30 am – 6:00 pm

Monday, November 4 6:30 am – 6:00 pm

Tuesday, November 5 6:30 am – 12:30 pm

Speaker Ready Room • Room 103B

Presenters should check-in 24 hours in advance, or no later than 2 hours prior to your session. If you are a speaker/presenter, review the presenter tab at www.thelivermeeting.org prior to the meeting for presentation tips, instructions, and guidelines.

Friday, November 1 6:30 am – 7:30 pm

Saturday, November 2 6:30 am – 7:30 pm

Sunday, November 3 6:30 am – 6:00 pm

Monday, November 4 6:30 am – 6:00 pm

Tuesday, November 5 6:30 am – 12:30 pm

Limited License for Use

  1. Top of page
  2. General Information
  3. Abstract Embargo
  4. ADA Compliance
  5. Limited License for Use

The Liver Meeting® is protected by copyright, trademark, and/or other applicable laws. Any use of The Liver Meeting®, including recordings and the development of derivative works, is prohibited. The name, logo and acronym of the American Association for the Study of Liver Diseases and The Liver Meeting ® are the exclusive property of and are trademarked by AASLD. They may not be used in any way, for any purpose, or at any time (including but not limited to announcements, invitations, emails, Web publications, etc.) without the express written permission of AASLD.

Without limiting the foregoing, Information presented during The Liver Meeting® is the property of AASLD and the presenter. Information may not be recorded, photographed, copied, photocopied, transferred to electronic format, reproduced, or distributed without the written permission of AASLD and the presenter. Any use of the program content which includes, but is not limited to, oral presentations, audiovisual materials used by speakers, and program handouts, without the written consent of AASLD is prohibited.

Notwithstanding the above, AASLD grants a non-exclusive, nontransferable, royalty-free license to nonprofit, §501(c) (3), AAMC-accredited educational institutions to conduct a “Best of AASLD” conference or similar event (“Event”) of up to eight (8) hours in length that features highlights from AASLD sessions at the most recent occurrence of The Liver Meeting® and to utilize the name of AASLD in connection with the same. No Event may be held, nor may the name of AASLD be utilized, except pursuant to this Limited License or as otherwise authorized by AASLD in writing.

When using the term “AASLD” or “The Liver Meeting®”, you must attribute AASLD's trademark as follows: The Liver Meeting ® and AASLD are registered trademarks of the American Association for the Study of Liver Diseases. You may not use the AASLD trademark(s):

  • In, as, or as part of your own trademarks
  • To identify products or services that do not belong to AASLD
  • In a manner likely to cause confusion, including colors and fonts
  • In a manner that implies inaccurately that AASLD sponsors or endorses, or is otherwise connected with your own activities, products and services

The content of an Event shall be of the highest quality and shall accurately reflect material and information presented at the AASLD sessions. No Event shall include any statements or other communication that maligns or disparages AASLD or any AASLD session, presenter, or representative.

All Event announcements, brochures, descriptions, and materials, whether in print or electronic form, shall clearly identify the content as being derived from AASLD sessions by including the following statement: “All content is derived from presentations and similar offerings made at The Liver Meeting® 20XX and is presented with permission of the American Association for the Study of Liver Diseases.” As between AASLD and any institution, AASLD is the owner of all AASLD programming and AASLD does not relinquish any such ownership rights by virtue of this Limited License.

AASLD disclaims all warranties, express and implied, as to any information or materials presented in connection with any AASLD session or meeting, including as to intellectual property ownership. AASLD shall not be liable for any direct, indirect, punitive, consequential, or other damages in any way arising or resulting from the Event or the use of information or materials from AASLD sessions by any institution. Should any claim or suit be brought against AASLD arising from an Event, the institution shall indemnify and hold AASLD harmless for any damages, liability, and costs, including attorney fees, suffered or incurred by AASLD in defense and satisfaction thereof.

This Limited License does not create a partnership, joint venture, or similar relationship between AASLD and any institution. This Limited License is non-transferable, including by sale or sublicense.

This Limited License shall terminate automatically upon violation of any of its terms. In addition, AASLD may terminate, or modify the terms of, this Limited License in its discretion, generally or with respect to any particular institution.

This Limited License shall be construed in accordance with the laws of the Commonwealth of Virginia, without regard to conflicts principles, and, as applicable, federal copyright and trademark laws. A court of competent jurisdiction in or for Alexandria, Virginia shall be the exclusive forum for the resolution of any dispute between AASLD and any institution, and institutions irrevocably consent to the personal and subject matter jurisdiction, and venue, of such court.